CYP1A1 and cancer: Moreover, AHR-CYP1A1 activation is associated with cancer progression and our transcriptional analysis also suggested that alizarin exposure may increase the risk of developing cancers; therefore, more in vivo and stringent tests should be performed for the safety of alizarin in the future.